Clinical trial
Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) From Plasma Into Human Brain
NCT00074503 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) From Plasma Into Human Brain
- Lead sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 12, 2003
- Completion date
- July 13, 2010
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy